The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characterization of long-term and short-term survivors of advanced pancreatic ductal adenocarcinoma.
 
Jesús Fuentes Antrás
No Relationships to Disclose
 
Gun Ho Jang
No Relationships to Disclose
 
James T. Topham
No Relationships to Disclose
 
Amy Zhang
No Relationships to Disclose
 
Erica S Tsang
No Relationships to Disclose
 
Yifan Wang
No Relationships to Disclose
 
Shawn Hutchinson
No Relationships to Disclose
 
Anna Dodd
No Relationships to Disclose
 
Julie Wilson
No Relationships to Disclose
 
Faiyaz Notta
No Relationships to Disclose
 
Sandra Fischer
No Relationships to Disclose
 
Stephanie Ramotar
No Relationships to Disclose
 
Shari Moura
Honoraria - Celgene
 
Sevan Hakgor
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Amgen; Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Hookipa Pharma; InterRNA; Janpix; Janssen; Merck; Navire; Oncorus; Relay Therapeutics; Roche; Sanofi; Seagen; Tessa Therapeutics; Voronoi Health Analytics
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)
 
George Zogopoulos
No Relationships to Disclose
 
Steven Gallinger
No Relationships to Disclose
 
Daniel Renouf
Honoraria - Celgene; Ipsen; Roche; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Celgene; SERVIER; Shire; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Grainne M. O'Kane
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - AstraZeneca Canada; Eisai; Incyte; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca